In a remarkable demonstration of the potential of private sector innovation, OpenAI has partnered with Retro Biosciences to develop a new AI model, GPT-4b micro. This initiative, driven by the entrepreneurial spirit of Sam Altman, aims to extend human lifespan by an unprecedented 10 years, a milestone covered by MIT Technology Review. The collaboration underscores the importance of deregulation and the role of private investment in unlocking the future of healthcare, advocating for a scenario where market-driven solutions outpace government interventions in achieving groundbreaking advancements.
OpenAI and Retro Biosciences: Free Market Innovation Leads the Way in Life Extension
All Versions
Jan-19
Technology
Score: 0.50
OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review. Retro, which is backed by Sam Altman, has been working with …
From Biztoc.com
Jan-19
Technology
Left Variant
Score: 0.20
In an inspiring collaboration between OpenAI and Retro Biosciences, spearheaded by industry visionary Sam Altman, the latest AI model, GPT-4b micro, is set to revolutionize our approach to longevity. This groundbreaking project, as highlighted by MIT Technology Review, promises to extend human life by a decade, potentially narrowing the health inequality gap. With the power of advanced AI, this initiative not only represents a significant scientific breakthrough but also aligns with broader progressive goals of enhancing public health and ensuring equitable access to cutting-edge medical innovations for all.
From Biztoc.com